Literature DB >> 1955116

Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea.

M R Clausen1, H Bonnén, M Tvede, P B Mortensen.   

Abstract

To elucidate the pathogenesis of antibiotic-associated diarrhea, colonic carbohydrate fermentation was investigated in three groups of subjects--a group of controls, a group of patients with antibiotic-associated diarrhea, and a group of patients receiving antibiotic therapy without diarrhea. Compared with controls, the colonic fermentation was markedly impaired in patients with antibiotic-associated diarrhea reflected by both very low concentrations (22.1 vs. 59.5 mmol/L; P less than 0.01) and production rates of short-chain fatty acids. In the group of patients without diarrhea, the effect on the colonic fermentation was dependent on the antibiotic administered. Penicillin and pivampicillin PO did not reduce the concentrations (69.9 and 66.7 mmol/L, respectively) or production rates. Dicloxacillin, erythromycin, and combined IV treatment with ampicillin, netilmicin, and metronidazole reduced both concentrations (27.1, 38.2, and 18.8 mmol/L; P less than 0.01) and production rates of short-chain fatty acids to levels seen in patients with diarrhea. L-Lactate and D-lactate concentrations were normal in all patients (less than 5 mmol/L), but lactate production was reduced in the patients who had reduced production of short-chain fatty acids, including patients with diarrhea. Thus, antibiotic-associated diarrhea was always related to reduced fecal concentrations and production rates of short-chain fatty acids and production rates of lactate. These results suggest that the antibiotic-associated diarrhea might be secondary to impaired colonic fermentation in otherwise disposed subjects, resulting in accumulation of luminal carbohydrate and/or decreased short-chain fatty acid-stimulated sodium and water absorption.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955116     DOI: 10.1016/0016-5085(91)90384-w

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  39 in total

1.  The role of colonic microbiota in lactose intolerance.

Authors:  Yan Zhong; Marion G Priebe; Roel J Vonk; Cheng-Yu Huang; Jean-Michel Antoine; Tao He; Hermie J M Harmsen; Gjalt W Welling
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

Review 2.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

Authors:  Roberto Berni Canani; Margherita Di Costanzo; Ludovica Leone; Monica Pedata; Rosaria Meli; Antonio Calignano
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

3.  Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study.

Authors:  Daniel J Merenstein; Tina P Tan; Aleksey Molokin; Keisha Herbin Smith; Robert F Roberts; Nawar M Shara; Mihriye Mete; Mary Ellen Sanders; Gloria Solano-Aguilar
Journal:  Gut Microbes       Date:  2015

Review 4.  Drug-induced diarrhoea.

Authors:  O Chassany; A Michaux; J F Bergmann
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

5.  Effect of oral antibiotics on intestinal production of propionic acid.

Authors:  A F Mellon; S A Deshpande; J C Mathers; K Bartlett
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

Review 6.  Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome.

Authors:  Allen K Greiner; Rao V L Papineni; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-01       Impact factor: 4.052

7.  Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial.

Authors:  R I Breuer; K H Soergel; B A Lashner; M L Christ; S B Hanauer; A Vanagunas; J M Harig; A Keshavarzian; M Robinson; J H Sellin; D Weinberg; D E Vidican; K L Flemal; A W Rademaker
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

8.  Shedding of Clostridium difficile, fecal beta-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime.

Authors:  E Chachaty; C Bourneix; S Renard; M Bonnay; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

9.  Effects of short chain fatty acids on gut morphology and function.

Authors:  W Scheppach
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

10.  Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis. A prospective evaluation.

Authors:  Andrea Hille; Markus K A Herrmann; Tereza Kertesz; Hans Christiansen; Robert M Hermann; Olivier Pradier; Heinz Schmidberger; Clemens-F Hess
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.